Nimbus (NB.1.8.1) Covid Variant: Key Symptoms Like Razor-Sharp Sore Throat You Shouldn’t Ignore
As of June 7, the Nimbus Covid strain has been responsible for about 37% of US infections in the last two weeks.
Asian, UK, and US cases of a novel Covid strain called ‘Nimbus,’ scientifically known as NB.1.8.1, have been noticeably on the rise. This Omicrom sub-variant is becoming more well-known because of its unique and excruciating sore throat symptoms. Patients have used the term “razor blade throat” to characterise the intensity of their throat agony. As of June 7, over 37% of US cases within two weeks were caused by Nimbus, according to data from the Centres for Disease Control and Prevention (CDC).
Cases of Nimbus worldwide
Nearly one-third of new cases have been linked to Nimbus, according to health officials. The NB.1.8.1 variation has been identified in at least 13 US states, including California, New York, New Jersey, and Illinois, according to the Global Initiative on Sharing All Influenza Data (GISAID).
In the UK, there have also been reports of this variation. In the week ending May 31, 947 people were hospitalised, representing a 10% increase in hospitalisation, according to the UK Health Security Agency (UKHSA).
Additionally, the CDC has verified that NB.1.8.1 has caused a significant increase in hospitalisations throughout China. Numerous Asian countries, including Singapore, Thailand, and India, have also reported a noticeable increase in infections.
Razor blade and further signs of NB.1.8.1 or Nimbus
Infected people have symptoms similar to Omicron, such as congestion, exhaustion, a slight cough, fever, loss of taste and smell, runny nose, appetite loss, and muscular aches, in addition to excruciating throat discomfort. Symptoms like nausea and diarrhoea are less frequent.
There are no distinctive features of the new variant. Usually, the symptoms are mild to severe. However, the risk of serious illness is still higher for the elderly and those with weakened immune systems.
The World Health Organisation (WHO) is presently monitoring NB.1.8.1, which was initially discovered in China earlier this year. A member of the Omicron family is NB.1.8.1. The NB.1.8.1 sub-variant does not cause major sickness, according to specialists. It seems to be very transmissible, though.
India’s COVID-19 cases
The Health Ministry reports that there are 5,976 ongoing Covid-19 cases in India. In the last 24 hours, 507 people have recovered from COVID-19. Over the past few weeks, India has seen an increase in Covid-19 cases because of novel Omicron sub-variants, specifically LF.7, XFG, JN.1, and the recently discovered NB.1.8.1.
